Company Diaceutics PLC

Equities

DXRX

GB00BJQTGV64

Business Support Services

Delayed London S.E. 09:22:35 2024-04-19 am EDT 5-day change 1st Jan Change
103.1 GBX +0.10% Intraday chart for Diaceutics PLC -0.87% +18.51%

Business Summary

Diaceutics PLC is a United Kingdom-based company, which is a provider of technology and solutions. The Company provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. The Company operates through three segments: Insight Solutions (Data), Engagement Solutions (Tech enabled services), and Advisory Services (Professional services). The Company’s DXRX - The Diagnostics Network is a diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of laboratories. It provides unrivalled access to multiple pipelines of real-world diagnostic testing data from a global network of laboratories. Its Tech Enabled Services offers clinical testing labs to provide enablement and educational services in novel biomarkers.

Number of employees: 151

Sales per Business

GBP in Million2021Weight2022Weight Delta
Platform - Insight Solutions
64.9 %
7 53.2 % 13 64.9 % +70.73%
Advisory Services
23.7 %
6 40.5 % 5 23.7 % -18.09%
Platform - Engagement Solutions
11.4 %
1 6.4 % 2 11.4 % +151.07%

Sales per region

GBP in Million2021Weight2022Weight Delta
North America
74.1 %
8 60.7 % 14 74.1 % +70.91%
Europe
13.8 %
4 26.0 % 3 13.8 % -25.59%
Asia and the Rest of the World
9.2 %
1 9.4 % 2 9.2 % +37.08%
United Kingdom
2.9 %
1 4.0 % 1 2.9 % +1.08%

Managers

Managers TitleAgeSince
Chief Executive Officer 40 08-05-31
Director of Finance/CFO - 22-03-17
Chief Operating Officer - 22-03-14
Chief Administrative Officer - -
Chief Tech/Sci/R&D Officer - 18-01-31
Director/Board Member 63 04-12-31
General Counsel - -
Corporate Officer/Principal - -
Corporate Officer/Principal - 21-09-30
Corporate Officer/Principal - 18-08-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member - 23-09-30
Chairman 61 21-01-03
Director/Board Member 63 04-12-31
Chief Executive Officer 40 08-05-31
Director/Board Member 73 19-03-13
Director of Finance/CFO - 22-03-17

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 84,696,786 55,442,991 ( 65.46 %) 0 65.46 %

Shareholders

NameEquities%Valuation
15,752,049 18.60 % 21 M p
Canaccord Genuity Wealth Ltd.
9.077 %
7,687,677 9.077 % 10 M p
Gresham House Asset Management Ltd. (Investment Management)
6.736 %
5,704,778 6.736 % 8 M p
Joh. Berenberg, Gossler & Co. KG (Investment Management)
6.405 %
5,425,207 6.405 % 7 M p
Danske Bank A/S (Investment Management)
6.131 %
5,193,103 6.131 % 7 M p
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
4.734 %
4,009,764 4.734 % 5 M p
Gresham House Asset Management Ltd.
4.569 %
3,869,604 4.569 % 5 M p
3,112,169 3.674 % 4 M p
Herald Investment Management Ltd.
3.555 %
3,011,000 3.555 % 4 M p
2,990,643 3.531 % 4 M p

Company contact information

Diaceutics Plc

Enterprise House 55-59 Adelaide Street

BT2 8FE, Belfast

+

http://www.diaceutics.com
address Diaceutics PLC(DXRX)

Group companies

NameCategory and Sector
Medical/Nursing Services
  1. Stock Market
  2. Equities
  3. DXRX Stock
  4. Company Diaceutics PLC